lung cancer
Conditions
Interventions
An epidural catheter was inserted at the T4-T5 interspace in the operating room just before starting the general anesthesia. An epidural test dose of 3mL lidocaine 10mg/mL, 5 mL ropivacaine 7.5 mg/mL
5 on the numerical rating scale: NRS), 60 mg oral loxoprofen or 25mg suppository diclofenac was administered as rescue medication.
An epidural catheter was inserted at the T4-T5 interspace in the oper
Sponsors
National Hospital Organization, Kanagawa Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: lung cancer patients who can undergo lobectomy and pneumonectomy, and who epidural catheter is inserted at the T4-T5 interspace in the operating room. patients who have signed the consent form to participate in this study. patients over 20 years old when participate in this study.
Exclusion criteria
Exclusion criteria: patients with serious complications (such as asthma, renal disease, gastric ulcer), which are contraindication of NSAIDs. patients over P 3 (ECOG) patients considered unsuitable for the study by a primary physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain score (NRS) after removing the thoracic epidural analgesia (TEA) | — |
Secondary
| Measure | Time frame |
|---|---|
| Daily pain score Times of oatient Controlled analgesia (PCA) injection of thoracic epidural analgesia Pain scale in the morning, evening and sleeping Occurrence rate and severity of adverse effects | — |
Countries
Japan
Contacts
Public ContactYasoo Sugiura
National Hospital Organization, Kanagawa National Hospital General Thoracic Surgery
Outcome results
None listed